Leavitt Chase C. 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Leavitt Chase C.
General Counsel/Secretary
Transactions
- Purchase
Common Stock
2022-01-28$1.63/sh+5,000$8,150→ 44,867 total - Purchase
Common Stock
2022-01-27$1.78/sh+8,500$15,130→ 39,867 total